Milestone Pharmaceuticals Inc. (MIST) stock forecast and price target
Price $0.52 · data as of November 13, 2026
12-month price target
Average target$4.57
Upside / downside+779.1%
Analysts7
ConsensusStrong buy
Low $1.00Average $4.57High $8.00
Gold marker: average target · white marker: today’s price ($0.52)
Analyst ratings
Strong buy 1Buy 5Hold 1Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-0.78 | −3.7% | $5M |
| Next fiscal year ends December 31, 2027 | $-0.64 | +17.4% | $17M |
| Next quarter ends December 31, 2026 | $-0.21 | −38.7% | $1M |
| Quarter after ends March 31, 2027 | $-0.15 | +23.3% | $1M |
Consensus of the analysts covering Milestone Pharmaceuticals, updated daily. In the last 30 days 0 estimates were raised and 1 lowered.
Frequently asked questions
What is the Milestone Pharmaceuticals stock price target?
The average 12-month target from 7 analysts is $4.57, 779.1% above the current price of $0.52 Targets range from $1.00 to $8.00.
Is Milestone Pharmaceuticals a buy according to analysts?
The consensus rating is “Strong buy” (1 strong buy, 5 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Milestone Pharmaceuticals expected to earn?
Analysts expect EPS of $-0.78 for the fiscal year ending December 31, 2026 and $-0.64 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.